Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Centessa Pharmaceuticals plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 45 | 49 | +4 |
| Shares | 70.3M | 72.6M | +2.24M (+3.2%) |
| Value | $435.4M | $469.6M | +$34.2M (+7.8%) |
New holders (5)
Institutions that held Centessa Pharmaceuticals plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,040,816 | $13.2M | 1.94% |
| Acuta Capital Partners, LLC | 323,349 | $2.09M | 1.52% |
| Rathbone Brothers plc | 31,300 | $202.5K | 0.00% |
| Qube Research & Technologies Ltd | 69 | $446 | 0.00% |
| NBC Securities, Inc. | 138 | $0 | 0.00% |
Sold out (1)
Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Simplex Trading, LLC | 38 | $0 |